DE69934426D1 - KREBSIMMUNTHERAPIE UND KREBSDIAGNOSE UNTER VERWENDUNG UNIVERSELLER TUMORASSOZIIERTER ANTIGENE EINSCHLIESSLICH hTERT - Google Patents
KREBSIMMUNTHERAPIE UND KREBSDIAGNOSE UNTER VERWENDUNG UNIVERSELLER TUMORASSOZIIERTER ANTIGENE EINSCHLIESSLICH hTERTInfo
- Publication number
- DE69934426D1 DE69934426D1 DE69934426T DE69934426T DE69934426D1 DE 69934426 D1 DE69934426 D1 DE 69934426D1 DE 69934426 T DE69934426 T DE 69934426T DE 69934426 T DE69934426 T DE 69934426T DE 69934426 D1 DE69934426 D1 DE 69934426D1
- Authority
- DE
- Germany
- Prior art keywords
- cancer
- universal
- tumeric
- assays
- immune therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title 2
- 238000003556 assay Methods 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108010017842 Telomerase Proteins 0.000 abstract 1
- 102100032938 Telomerase reverse transcriptase Human genes 0.000 abstract 1
- 238000002619 cancer immunotherapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001154—Enzymes
- A61K39/001157—Telomerase or TERT [telomerase reverse transcriptase]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10610698P | 1998-10-29 | 1998-10-29 | |
US106106P | 1998-10-29 | ||
PCT/US1999/025438 WO2000025813A1 (en) | 1998-10-29 | 1999-10-29 | CANCER IMMUNOTHERAPHY AND DIAGNOSIS USING UNIVERSAL TUMOR ASSOCIATED ANTIGENS, INCLUDING hTERT |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69934426D1 true DE69934426D1 (de) | 2007-01-25 |
DE69934426T2 DE69934426T2 (de) | 2007-10-04 |
Family
ID=22309530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69934426T Revoked DE69934426T2 (de) | 1998-10-29 | 1999-10-29 | KREBSIMMUNTHERAPIE UND KREBSDIAGNOSE UNTER VERWENDUNG UNIVERSELLER TUMORASSOZIIERTER ANTIGENE EINSCHLIESSLICH hTERT |
Country Status (7)
Country | Link |
---|---|
US (1) | US7851591B1 (de) |
EP (1) | EP1126872B1 (de) |
AT (1) | ATE347904T1 (de) |
AU (1) | AU1331100A (de) |
CA (1) | CA2344972A1 (de) |
DE (1) | DE69934426T2 (de) |
WO (1) | WO2000025813A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1068296B1 (de) | 1998-03-31 | 2011-08-10 | Geron Corporation | Zusammensetzungen zur auslösung einer immunantwort gegen ein telomerase antigen |
US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
WO2000061766A2 (en) * | 1999-04-09 | 2000-10-19 | Biomira, Inc. | Telomerase-specific cancer vaccine |
EP1241945A4 (de) * | 1999-11-15 | 2005-08-17 | Dana Farber Cancer Inst Inc | Krebs immunotherapie und diagnose unter verwendung von cytochrom p450 |
JP2004527449A (ja) * | 2000-02-15 | 2004-09-09 | リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | テロメラーゼ逆転写酵素を用いる癌を治療するための万能ワクチンと方法 |
US20040191260A1 (en) | 2003-03-26 | 2004-09-30 | Technion Research & Development Foundation Ltd. | Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof |
FR2812087B1 (fr) * | 2000-07-21 | 2007-05-11 | Inst Nat Sante Rech Med | Procede de criblage de peptides utilisables en immunotherapie |
US7385023B1 (en) | 2000-11-15 | 2008-06-10 | Trustees Of Boston University | Cancer immunotherapy and diagnosis using cytochrome P450 1B1 |
GB0105238D0 (en) * | 2001-03-02 | 2001-04-18 | Norsk Hydro As | Vaccines |
US7745140B2 (en) | 2002-01-03 | 2010-06-29 | The Trustees Of The University Of Pennsylvania | Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool |
WO2003057171A2 (en) | 2002-01-03 | 2003-07-17 | The Trustees Of The University Of Pennsylvania | Activation and expansion of t-cells using an engineered multivalent signaling platform |
US7638326B2 (en) | 2002-01-03 | 2009-12-29 | The Trustees Of The University Of Pennsylvania | Activation and expansion of T-cells using an engineered multivalent signaling platform |
WO2003070752A2 (en) * | 2002-02-20 | 2003-08-28 | Dyax Corporation | Mhc-peptide complex binding ligands |
US20040072262A1 (en) * | 2002-10-11 | 2004-04-15 | Montero-Julian Felix A. | Methods and systems for detecting MHC class I binding peptides |
CN1306027C (zh) * | 2002-12-12 | 2007-03-21 | 中国医学科学院基础医学研究所 | 一种体外扩增γδT淋巴细胞的方法 |
US7754482B2 (en) | 2004-05-27 | 2010-07-13 | The Trustees Of The University Of Pennsylvania | Artificial antigen presenting cells and uses therefor |
US7678379B2 (en) | 2004-06-17 | 2010-03-16 | Beckman Coulter, Inc. | Mycobacterium tuberculosis epitopes and methods of use thereof |
EP2280731A1 (de) | 2008-04-09 | 2011-02-09 | Technion Research and Development Foundation, Ltd. | Anti-human-immunschwäche-antikörper und ihre verwendung |
EP2337795A2 (de) * | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc-multimere in krebsimpfstoffen und der untersuchung der immunreaktion |
LT2536830T (lt) | 2010-02-16 | 2019-11-11 | Ultimovacs Asa | Polipeptidai |
EP2388014A1 (de) * | 2010-05-21 | 2011-11-23 | Dorkoosh, Farid Abedin | Therapeutische Anwendung von tumoralen Peptiden mit variabler Immunoglobulinregion bei Patienten mit B-Zell-Malignomen |
US9499855B2 (en) * | 2013-03-14 | 2016-11-22 | Elwha Llc | Compositions, methods, and computer systems related to making and administering modified T cells |
KR20170032406A (ko) | 2014-07-15 | 2017-03-22 | 주노 쎄러퓨티크스 인코퍼레이티드 | 입양 세포 치료를 위한 조작된 세포 |
US10568948B2 (en) | 2015-05-13 | 2020-02-25 | Agenus Inc. | Vaccines for treatment and prevention of cancer |
MA42895A (fr) | 2015-07-15 | 2018-05-23 | Juno Therapeutics Inc | Cellules modifiées pour thérapie cellulaire adoptive |
EP3518955A4 (de) | 2016-09-30 | 2020-10-07 | The Wistar Institute Of Anatomy And Biology | Tert-immunogene zusammensetzungen und behandlungsverfahren damit |
EP3784688A2 (de) | 2018-04-26 | 2021-03-03 | Agenus Inc. | Hitzeschockproteinbindende peptidzusammensetzungen und verfahren zu deren verwendung |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5679647A (en) * | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
US5686068A (en) | 1994-03-24 | 1997-11-11 | Ludwig Institute For Cancer Research | Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof |
US5770422A (en) * | 1996-07-08 | 1998-06-23 | The Regents Of The University Of California | Human telomerase |
US5747317A (en) * | 1996-07-08 | 1998-05-05 | Tularik Inc. | Human telomerase RNA interacting protein gene |
SG94355A1 (en) | 1996-10-01 | 2003-02-18 | Geron Corp | Human telomerase catalytic subunit |
US6475789B1 (en) * | 1996-10-01 | 2002-11-05 | University Technology Corporation | Human telomerase catalytic subunit: diagnostic and therapeutic methods |
WO1998037181A2 (en) | 1997-02-20 | 1998-08-27 | Whitehead Institute For Biomedical Research | Telomerase catalytic subunit gene and encoded protein |
EP1068296B1 (de) | 1998-03-31 | 2011-08-10 | Geron Corporation | Zusammensetzungen zur auslösung einer immunantwort gegen ein telomerase antigen |
US7030211B1 (en) * | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
-
1999
- 1999-10-29 WO PCT/US1999/025438 patent/WO2000025813A1/en active IP Right Grant
- 1999-10-29 AT AT99956777T patent/ATE347904T1/de not_active IP Right Cessation
- 1999-10-29 DE DE69934426T patent/DE69934426T2/de not_active Revoked
- 1999-10-29 CA CA002344972A patent/CA2344972A1/en not_active Abandoned
- 1999-10-29 EP EP99956777A patent/EP1126872B1/de not_active Revoked
- 1999-10-29 US US09/830,400 patent/US7851591B1/en not_active Expired - Fee Related
- 1999-10-29 AU AU13311/00A patent/AU1331100A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7851591B1 (en) | 2010-12-14 |
CA2344972A1 (en) | 2000-05-11 |
EP1126872A1 (de) | 2001-08-29 |
ATE347904T1 (de) | 2007-01-15 |
EP1126872A4 (de) | 2003-01-02 |
EP1126872B1 (de) | 2006-12-13 |
AU1331100A (en) | 2000-05-22 |
DE69934426T2 (de) | 2007-10-04 |
WO2000025813A1 (en) | 2000-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69934426D1 (de) | KREBSIMMUNTHERAPIE UND KREBSDIAGNOSE UNTER VERWENDUNG UNIVERSELLER TUMORASSOZIIERTER ANTIGENE EINSCHLIESSLICH hTERT | |
PL366575A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
WO1999004265A3 (en) | Cancer associated nucleic acids and polypeptides | |
DE69727966D1 (de) | Ein mit krebs assoziiertes antigen kodierendes isoliertes nukleinsäuremolekül, das antigen selbst, und dessen verwendungen | |
ZA945364B (en) | Antibodies specific for human prostate glandular kallikrein | |
HK1046287A1 (en) | Ibd-associated microbial antigens and methods of using same | |
TR200001253T2 (tr) | Tümöre özel antijenler | |
ES2176574T3 (es) | Utilizacion de anticuerpos bi y triespecificos para la induccion de inmunidad tumoral. | |
IL195338A0 (en) | Optimized fc variants and methods for their generation | |
DE69924826T8 (de) | Verwendung vom krebs-assoziierten antigen 5t4 zur immuntherapie | |
MXPA05014016A (es) | Proteinas portadoras para vacunas. | |
CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
ATE90877T1 (de) | Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen. | |
EP1572087A4 (de) | Antikörper gegen krebsantigen tmeff2 und seine anwendungen | |
NO965395D0 (no) | Humane, monoklonale antistoffer som er spesifikke mot cellecyklus-uavhengig gliom-overflateantigen | |
DE60315827D1 (de) | Verbesserte polysaccharid- und glykokonjugat-vakzine | |
TR200102034T2 (tr) | Anti kanser aşılaması için antikorların kullanılması | |
UY26266A1 (es) | Antigeno asociado con tumores (r11) ley 17164 | |
WO2000060080A3 (en) | Molecules of the immune system | |
AU2911289A (en) | Carcinoma-associated antigens, and antibodies which recognize these antigens | |
WO2003024302A3 (en) | Detection and treatment of cancers of breast | |
UY26170A1 (es) | Antigeno (c42) asociados a tumores | |
WO1999031225A3 (en) | Human phosphatases | |
WO2003024304A3 (en) | Detection and treatment of cancers of the liver | |
CY1109583T1 (el) | Κυτοκινες θηλαστικων, αντιστοιχα αντιδραστηρια |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8331 | Complete revocation |